Krishnaswamy Yeleswaram - 06 Jun 2024 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Role
Chief Development Officer
Signature
/s/ Cheryl Gault, Attorney-in-Fact
Issuer symbol
RAPP
Transactions as of
06 Jun 2024
Transactions value $
$0
Form type
4
Filing time
10 Jun 2024, 19:42:12 UTC
Next filing
04 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPP Stock Option (Right to Buy) Award $0 +84.9K $0.00 84.9K 06 Jun 2024 Common Stock 84.9K $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest and become exercisable on June 6, 2025, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.